RecruitingNCT01886950
Evolution of Bone Histomorphometry and Vascular Calcification Before and After Renal Transplantation
A Prospective Observational Study to Investigate the Natural History of Bone Histomorphometry and Vascular Calcification in Dialysis-dependent Patients Before and After Renal Transplantation.
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
250 participants
Start Date
Aug 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
A study of the natural history of bone and mineral disease (BMD) in patients with end-stage renal disease before and after kidney transplantation
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- eligible for renal transplantation and \>18 years
Exclusion Criteria1
- use of biphosphonates within the 6 months before the study entry
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01886950
Related Trials
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945102 locations
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660153 locations
A Prospecitve Multicenter, Observational Registry Study
NCT074815261 location
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
NCT05457283178 locations
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
NCT072325371 location